{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:13:30Z","timestamp":1790039610782,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Synthetic cannabinoids have become increasingly popular drugs of abuse due to low cost and inability to detect these substances on routine drug screenings. In the United States, incidence of synthetic cannabinoid contamination with long-acting anticoagulant rodenticides (LAARs) resulting in coagulopathy and bleeding complications has been described.<\/jats:p>\n            <jats:p>We sought to describe the natural history, management approach, and outcomes of bleeding secondary to synthetic cannabinoid-associated LAAR toxicity in an observational case series of patients evaluated at an urban academic medical system.<\/jats:p>\n            <jats:p>We conducted an observational study of patients with suspected exposure to LAAR-contaminated synthetic cannabinoids and associated bleeding treated within the Johns Hopkins Health System.<\/jats:p>\n            <jats:p>In this 16 subject cohort, hematuria was the most common bleeding symptom at presentation. The majority of the cohort (75%) had international normalized ratio (INR)\u200a&gt;\u200a9.6 at presentation. Of the 13 patients with brodifacoum testing, 12\/13 (92%) were positive. Twelve patients (75%) had at least 1 INR value below 2 within 24\u200ahours of the first INR measurement. Of this cohort, 1\/16 (6%) died in hospital. The median length of hospital stay was 4 days, (interquartile range\u200a=\u200a3\u20136). The average cost of pharmacological treatment for coagulopathy during inpatient hospitalization was $5300 (range, $2241\u2013$8086).<\/jats:p>\n            <jats:p>In patients presenting with unexplained coagulopathy it is important for emergency department providers to consider LAAR intoxication and consider formal testing for brodifacoum to assist with treatment planning. Use of a standardized management algorithm including intravenous\/oral vitamin K, judicious use of blood products and close laboratory monitoring is essential to optimizing outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017015","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T09:58:08Z","timestamp":1567677488000},"page":"e17015","source":"Crossref","is-referenced-by-count":12,"title":["Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides"],"prefix":"10.1097","volume":"98","author":[{"given":"Mona N.","family":"Bahouth","sequence":"first","affiliation":[{"name":"Cerebrovascular Division, Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Kraus","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Dane","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Plazas Montana","sequence":"additional","affiliation":[{"name":"Department of Hematology, Johns Hopkins Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tsao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burton","family":"Tabaac","sequence":"additional","affiliation":[{"name":"Cerebrovascular Division, Department of Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagar","family":"Jasem","sequence":"additional","affiliation":[{"name":"Department of Hematology, Johns Hopkins Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Schmidlin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Einstein","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Center, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Streiff","sequence":"additional","affiliation":[{"name":"Department of Hematology, Johns Hopkins Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Shanbhag","sequence":"additional","affiliation":[{"name":"Department of Hematology, Johns Hopkins Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"607","DOI":"10.15585\/mmwr.mm6721a4","article-title":"Notes from the field: outbreak of severe illness linked to the Vitamin K antagonist brodifacoum and use of synthetic Cannabinoids \u2014 Illinois, March\u2013April 2018","volume":"67","author":"Moritz","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5409\/wjcp.v5.i1.16","article-title":"Synthetic cannabinoids 2015: an update for pediatricians in clinical practice","volume":"5","author":"Castellanos","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2015.06.002","article-title":"Long-acting anticoagulant rodenticide (Superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management","volume":"29","author":"King","year":"2015","journal-title":"Transfus Med Rev"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.13085","article-title":"The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures","volume":"1374","author":"Feinstein","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.158.10.1140","article-title":"Effect of Warfarin on activated partial thromboplastin time in patients receiving heparin","volume":"158","author":"Kearon","year":"1998","journal-title":"Arch Intern Med"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1160\/TH15-11-0892","article-title":"Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists","volume":"116","author":"Bleker","year":"2016","journal-title":"Thromb Haemost"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"pii: bcr2014206360","DOI":"10.1136\/bcr-2014-206360","article-title":"Superwarfarin poisoning and its management","volume":"2014","author":"Card","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/phar.1270","article-title":"Reversal of oral anticoagulation","volume":"33","author":"Thigpen","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mpmed.2015.12.012","article-title":"Warfarin and anticoagulant rodenticides","volume":"44","author":"Bradberry","year":"2016","journal-title":"Medicine"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/15563650701354093","article-title":"Brodifacoum poisoning with toxicokinetic data","volume":"45","author":"Olmos","year":"2007","journal-title":"Clin Toxicol (Phila)"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/archinte.1993.00410160099010","article-title":"Case management and plasma half-life in a case of brodifacoum poisoning","volume":"153","author":"Hollinger","year":"1993","journal-title":"Arch Intern Med"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ajh.20784","article-title":"Superwarfarin poisoning: a report of two cases and review of the literature","volume":"82","author":"Spahr","year":"2007","journal-title":"Am J Hematol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM200108303450916","article-title":"Severe coagulopathy as a consequence of smoking crack cocaine laced with rodenticide","volume":"345","author":"Waien","year":"2001","journal-title":"N Engl J Med"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.1984.03350210052030","article-title":"Human ingestion of a superwarfarin rodenticide resulting in a prolonged anticoagulant effect","volume":"252","author":"Lipton","year":"1984","journal-title":"JAMA"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1067\/mem.2000.108317","article-title":"Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing","volume":"36","author":"Bruno","year":"2000","journal-title":"Ann Emerg Med"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V76.12.2555.2555","article-title":"Surreptitious ingestion of a long-acting vitamin k antagonist\/rodenticide, brodifacoum: clinical and metabolic studies of three cases","volume":"76","author":"Weitzel","year":"1990","journal-title":"Blood"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0196-0644(05)80900-X","article-title":"Fatal rodenticide poisoning with brodifacoum","volume":"21","author":"Kruse","year":"1992","journal-title":"Ann Emerg Med"},{"key":"R23-20230914","first-page":"67","article-title":"Brodifacoum intoxication with marijuana smoking","volume":"121","author":"La Rosa","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00228-012-1362-y","article-title":"VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation","volume":"69","author":"Marinova","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa1807652","article-title":"An outbreak of synthetic cannabinoid\u2013associated coagulopathy in Illinois","volume":"379","author":"Kelkar","year":"2018","journal-title":"N Engl J Med"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/phar.2241","article-title":"Synthetic cannabinoid-associated multiple organ failure: case series and literature review","volume":"39","author":"Armstrong","year":"2019","journal-title":"Pharmacotherapy"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage","volume":"24","author":"Frontera","year":"2015","journal-title":"Neurocrit Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:07:48Z","timestamp":1694725668000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017015"}},"subtitle":["Observational case series and management recommendations"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017015","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}